Corrigendum to "Patient tissue-derived FGFR4-variant and wild-type colorectal cancer organoid development and anticancer drug sensitivity testing" [Heliyon Vol 10, Iss 10, May 2024, Article e30985]

Heliyon. 2024 Nov 15;10(23):e39990. doi: 10.1016/j.heliyon.2024.e39990. eCollection 2024 Dec 15.

Authors

Hailing Lin¹, Hongbo Fu¹, Shishen Sun², Hao Yin², Jie Yuan², Jilin Liao^{1

3}

Affiliations

¹ Department of Pharmacy, The Second Affiliated Hospital, Shantou University Medical College, Shantou, 515041, Guangdong, China.
² Department of General Surgery, Foshan Clinical Medical School, Guangzhou University of Chinese Medicine, Foshan, 528000, Guangdong, China.
³ Department of Pharmacology, Shantou University Medical College, Shantou, Guangdong, 515041, China.

Abstract

[This corrects the article DOI: 10.1016/j.heliyon.2024.e30985.].

© 2024 The Author(s).

Publication types

Published Erratum